Listar por autor "Punie, Kevin"
Mostrando ítems 1-4 de 4
-
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Bardia, Aditya; Tolaney, Sara M; Punie, Kevin; Loirat, Delphine; Antunes de Melo Oliveira, Ana Mafalda; Kalinsky, K. (Elsevier, 2021-09) -
Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis
Carey, Lisa; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Dieras, Veronique; Dalenc, Florence; Cortés Castan, Javier (Nature Research, 2022-06-09) -
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
Rugo, Hope; Tolaney, Sara M; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara; Cortés Castan, Javier (Breast Cancer Research Foundation, 2022-08-29) -
The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series
Lim, Kok Haw Jonathan; Murali, Krithika; Thorne, Eleanor; Punie, Kevin; Kamposioras, Konstantnos; Oing, Christoph; Elez Fernandez, Mª Elena (Elsevier, 2022-02)